New Hampshire HB 659: relative to reporting of internal pharmaceutical costs.

Status: Inexpedient to Legislate: MA VV 03/19/2019 HJ 10 P. 14 (as of 2019-03-19)

State: New Hampshire · Session: 2019 · Bill: HB 659

View New Hampshire HB 659 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.